The achievements of cell-based therapeutics over the last decades have bolstered efforts in recent years to bring more of these products to market and across an ever ...

Cancer therapeutics have come a long way in a short time span, leading to significant paradigm shifts in drug discovery. The emergence of checkpoint inhibitors that t...

When defining the term gold standard, the most appropriate definition is “a benchmark test that is the best available under reasonable conditions”. Rafal Ziecina at W...

As new biological therapies continue to be developed, the market has seen an increased need for innovation. Demand  has grown for improved operational efficiency and ...

Biorepositories are a key asset for many organisations including those in the biotechnology, pharmaceutical and medical research areas. As they may contain human tiss...

Data integrity remains an important topic in pharmaceutical and biopharmaceutical manufacturing science. The purpose of data integrity is to ensure that the accurate ...

Drug discovery takes years to complete. Testing a single compound can cost more than £1.5 billion. Experiments on animals often fail to predict human behaviours and r...

As temperature-sensitive pharmaceutical products are increasingly being shipped globally to more remote regions, there is an even greater demand for the effective and...